https://www.coltonconsortium.org/directory/jason-christie-md-msce/
Paul F. Harron, Jr. Family Chair, Department of Medicine, Perelman School of Medicine, University of Pennsylvania Dr. Jason Christie is the Paul F. Harron, Jr. Family Chair, Chief of the […]
https://www.coltonconsortium.org/directory/jill-p-buyon-md/
Sir Deryck and Lady Va Maughan Professor of Rheumatology, Department of Medicine, NYU Grossman School of Medicine / NYU Langone Health Director, Division of Rheumatology, NYU Grossman School of Medicine […]
https://www.coltonconsortium.org/directory/benjamin-abramoff-md-ms/
Associate Professor, Department of Physical Medicine and Rehabilitation, Perelman School of Medicine, University of Pennsylvania Dr. Benjamin Abramoff is an Assistant Professor of Physical Medicine and Rehabilitation at the Perelman […]
https://www.coltonconsortium.org/directory/amit-bar-or-md-frcp-faan-fana/
Melissa and Paul Anderson President’s Distinguished Professor, Department of Neurology, Perelman School of Medicine, University of Pennsylvania Dr. Amit Bar-Or is the inaugural Melissa and Paul Anderson President’s Distinguished Professor […]
https://www.coltonconsortium.org/projects/targeted-biologic-therapy-for-autoimmune-disease-associated-with-dnaseil3-deficiency/
Developing a bioavailable DNAseIL3 biologic to degrade pathogenic autoantibodies and treat lupus and related autoimmune diseases.
https://www.coltonconsortium.org/projects/ai-simulated-in-silico-humans-a-new-paradigm-for-modeling-autoimmunity/
Building AI-powered digital avatars that simulate each patient's immune system to predict therapy response and accelerate precision immunotherapy development.
https://www.coltonconsortium.org/projects/center-of-excellence-for-cell-therapy-in-autoimmunity-cecta/
Advancing engineered CAR and CAAR T cell therapies across multiple autoimmune diseases through clinical trials, preclinical development, and industry partnerships.
https://www.coltonconsortium.org/projects/high-throughput-center-for-autoimmune-therapeutic-discovery-hit-ai/
Systematically identifying and validating repurposed FDA-approved drugs for over 160 autoimmune diseases using AI, knowledge graphs, and high-throughput experimental screening.
https://www.coltonconsortium.org/projects/colton-center-for-rna-exploration-in-autoimmune-therapeutics-create/
Developing next-generation mRNA-LNP therapeutics that selectively modulate or deplete pathogenic immune cells to treat type 1 diabetes, lupus, multiple sclerosis, and other severe autoimmune conditions.
https://www.coltonconsortium.org/publications/tolebrutinib-in-nonrelapsing-secondary-progressive-multiple-sclerosis/